Skip to main content
NCBI home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2000 May-Jun;6(3):283–289. doi: 10.3201/eid0603.000308

High prevalence of penicillin-nonsusceptible Streptococcus pneumoniae at a community hospital in Oklahoma.

R L Moolenaar 1, R Pasley-Shaw 1, J R Harkess 1, A Lee 1, J M Crutcher 1
PMCID: PMC2640867  PMID: 10827118

Abstract

During 1997, Oklahoma City's Hospital A reported penicillin-nonsusceptible Streptococcus pneumoniae in almost 67% of isolates. To confirm this finding, all Hospital A S. pneumoniae isolates from October 23, 1997, through February 19, 1998, were tested for antibiotic susceptibility and repeat-tested at two other hospital laboratories. Medical records of Hospital A patients with invasive S. pneumoniae infections during 1994 through 1997 were also reviewed. These data were compared with 1998 statewide sentinel hospital surveillance data for invasive S. pneumoniae. Of 48 S. pneumoniae isolates from Hospital A during October 23, 1997, through February 19, 1998, 31 (65%) were penicillin-nonsusceptible S. pneumoniae, and 23 (48%) were highly penicillin resistant. Similar prevalences were confirmed at the other hospital laboratories; however, significant interlaboratory differences were noted in the determination of third-generation cephalosporin susceptibility. During 1994 through 1997, a trend toward increasing penicillin nonsusceptibility (p <0.05) was noted among S. pneumoniae isolates from nursing home patients. During 1998, 85 (30%) of 282 invasive isolates reported to the state surveillance system were penicillin-nonsusceptible S. pneumoniae; 33 (12%) were highly resistant. The increase in resistance observed is notable; the interlaboratory discrepancies are unexplained. To respond, a vaccination program was implemented at Hospital A, and vaccination efforts were initiated at nursing homes.

Full Text

The Full Text of this article is available as a PDF (33.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Breiman R. F., Butler J. C., Tenover F. C., Elliott J. A., Facklam R. R. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 1994 Jun 15;271(23):1831–1835. [PubMed] [Google Scholar]
  2. Butler J. C., Cetron M. S. Pneumococcal drug resistance: the new "special enemy of old age". Clin Infect Dis. 1999 Apr;28(4):730–735. doi: 10.1086/515220. [DOI] [PubMed] [Google Scholar]
  3. Butler J. C., Hofmann J., Cetron M. S., Elliott J. A., Facklam R. R., Breiman R. F. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis. 1996 Nov;174(5):986–993. doi: 10.1093/infdis/174.5.986. [DOI] [PubMed] [Google Scholar]
  4. Bédos J. P., Chevret S., Chastang C., Geslin P., Régnier B. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin Infect Dis. 1996 Jan;22(1):63–72. doi: 10.1093/clinids/22.1.63. [DOI] [PubMed] [Google Scholar]
  5. Centers for Disease Control and Prevention (CDC) Influenza and pneumococcal vaccination levels among adults aged > or =65 years--United States, 1997. MMWR Morb Mortal Wkly Rep. 1998 Oct 2;47(38):797–802. [PubMed] [Google Scholar]
  6. Chin A. E., Hedberg K., Cieslak P. R., Cassidy M., Stefonek K. R., Fleming D. W. Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method. Emerg Infect Dis. 1999 Sep-Oct;5(5):688–693. doi: 10.3201/eid0505.990510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frick P. A., Black D. J., Duchin J. S., Deliganis S., McKee W. M., Fritsche T. R. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State. West J Med. 1998 Dec;169(6):364–369. [PMC free article] [PubMed] [Google Scholar]
  8. Gonzales R., Steiner J. F., Lum A., Barrett P. H., Jr Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999 Apr 28;281(16):1512–1519. doi: 10.1001/jama.281.16.1512. [DOI] [PubMed] [Google Scholar]
  9. Gyorkos T. W., Tannenbaum T. N., Abrahamowicz M., Bédard L., Carsley J., Franco E. D., Delage G., Miller M. A., Lamping D. L., Grover S. A. Evaluation of the effectiveness of immunization delivery methods. Can J Public Health. 1994 Jul-Aug;85 (Suppl 1):S14–S30. [PubMed] [Google Scholar]
  10. Haglund L. A., Istre G. R., Pickett D. A., Welch D. F., Fine D. P. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. Pneumococcus Study Group. J Infect Dis. 1993 Dec;168(6):1532–1536. doi: 10.1093/infdis/168.6.1532. [DOI] [PubMed] [Google Scholar]
  11. Heffernan R., Henning K., Labowitz A., Hjelte A., Layton M. Laboratory survey of drug-resistant Streptococcus pneumoniae in New York City, 1993-1995. Emerg Infect Dis. 1998 Jan-Mar;4(1):113–116. doi: 10.3201/eid0401.980116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hofmann J., Cetron M. S., Farley M. M., Baughman W. S., Facklam R. R., Elliott J. A., Deaver K. A., Breiman R. F. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. 1995 Aug 24;333(8):481–486. doi: 10.1056/NEJM199508243330803. [DOI] [PubMed] [Google Scholar]
  13. Istre G. R., Tarpay M., Anderson M., Pryor A., Welch D. Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance. J Infect Dis. 1987 Nov;156(5):732–735. doi: 10.1093/infdis/156.5.732. [DOI] [PubMed] [Google Scholar]
  14. Jernigan D. B., Cetron M. S., Breiman R. F. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group. JAMA. 1996 Jan 17;275(3):206–209. [PubMed] [Google Scholar]
  15. Klein R. S., Adachi N. An effective hospital-based pneumococcal immunization program. Arch Intern Med. 1986 Feb;146(2):327–329. [PubMed] [Google Scholar]
  16. Macias E. A., Mason E. O., Jr, Ocera H. Y., LaRocco M. T. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J Clin Microbiol. 1994 Feb;32(2):430–432. doi: 10.1128/jcm.32.2.430-432.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nuorti J. P., Butler J. C., Crutcher J. M., Guevara R., Welch D., Holder P., Elliott J. A. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med. 1998 Jun 25;338(26):1861–1868. doi: 10.1056/NEJM199806253382601. [DOI] [PubMed] [Google Scholar]
  18. Pastor P., Medley F., Murphy T. V. Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995. Clin Infect Dis. 1998 Mar;26(3):590–595. doi: 10.1086/514589. [DOI] [PubMed] [Google Scholar]
  19. Postema A. S., Breiman R. F., National Vaccine Advisory Committee Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation. MMWR Recomm Rep. 2000 Mar 24;49(RR-1):1–13. [PubMed] [Google Scholar]
  20. Tenover F. C., Baker C. N., Swenson J. M. Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae. J Clin Microbiol. 1996 Jan;34(1):10–14. doi: 10.1128/jcm.34.1.10-14.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Vondracek T. G., Pham T. P., Huycke M. M. A hospital-based pharmacy intervention program for pneumococcal vaccination. Arch Intern Med. 1998 Jul 27;158(14):1543–1547. doi: 10.1001/archinte.158.14.1543. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES